Scientists have created a near-copy of the long-extinct dire wolf. Using advanced CRISPR gene editing tech, it now looks ...

LLY's move to buy Verve ignites investor interest across gene-editing stocks like CRSP, NTLA and BEAM in a booming M&A year.

CRISPR construct to genetically ablate the GABA transporter GAT3 in the mouse visual cortex, with effects on population-level neuronal activity. This work is important, as it sheds light on how GAT3 ...

Emerging oligonucleotides and gene editing therapies offer greater precision, long-term efficacy, and improved adherence in comparison to traditional statin therapies. This is especially true for ...

Scientific organizations recently called for a 10-year ban on human germline editing. But will we ever be ready? And how would we even know?

When it comes to cutting-edge health technology, Jecizer Biosciences is quickly becoming the name you’ve probably haven’t ...

The authors proposed two hypotheses: first, that methamphetamine induces neuroinflammation, and second, that it alters neuronal stem cell differentiation. These are valuable hypotheses, and the ...

Chip Wilson, the visionary entrepreneur who fundamentally reshaped the world of athletic apparel with Lululemon, is now engaged in perhaps his most important challenge: a deeply personal fight against ...

The global CRISPR gene editing market size is calculated at USD 4.77 billion in 2025 and is expected to reach around USD ...

A St. Louis startup is pioneering a new approach to gene editing in crops, and the National Science Foundation just gave it a ...

Metagenomi Inc. (NASDAQ: MGX) is one of the best young stocks to buy and hold for 5 years. In mid-May, Metagenomi announced ...

Researchers have developed a new gene-editing platform that will enable safer and more effective T cell–based immunotherapies ...